⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for braf rearrangement

Every month we try and update this database with for braf rearrangement cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCNCT03333343
EGFR-mutant Non...
EGF816
trametinib
ribociclib
LXH254
INC280
gefitinib
18 Years - Novartis
Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCNCT03333343
EGFR-mutant Non...
EGF816
trametinib
ribociclib
LXH254
INC280
gefitinib
18 Years - Novartis
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)NCT06159478
Low-grade Gliom...
Pancreatic Canc...
Binimetinib 15 ...
12 Years - National Cancer Center, Japan
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: